Allergan Alphagan pediatric data
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Allergan's glaucoma agents Alphagan and Alphagan P (brimonidine) gain approval Dec. 20 for use in pediatric glaucoma patients ages 2 to 6